Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDeltex Medical Regulatory News (DEMG)

  • There is currently no data for DEMG

Director Shareholding

13 May 2005 13:15

Deltex Medical Group PLC13 May 2005 Deltex Medical Group plc Directors' Shareholdings Deltex Medical Group plc (the "Company"), the AIM quoted haemodynamic monitoringcompany, announces that Nigel Keen, Chairman and Ewan Phillips, Finance Directoryesterday purchased a total of 87,900 and 12,100 ordinary shares at an averageprice of 19.2 pence per share respectively in the market. The Company also announces that it has today issued a total of 98,518 newordinary shares in the Company to certain non-executive directors at a price of203/4 pence per share based on yesterday's closing mid-market price. The four non-executive directors named below have elected to take shares in lieuof a cash payment as remuneration for their services to the Company. Accordingly, application has been made for these shares to be admitted totrading on AIM. The shares rank pari passu with the existing issued shares ofthe Company and dealings are expected to commence on 20 May 2005. Followingthese shares being admitted to trading on AIM, the number of shares in issuewill be 69,576,111. Following the purchase of shares by the directors and the issue of new ordinaryshares, the directors' beneficial interests are as follows: Name of Director Number of new Number of shares Holding of shares % of enlarged ordinary shares purchased in following issue of issued share issued in lieu of market new ordinary shares capital fees and purchases in market Nigel Keen (1) 30,120 87,900 3,797,937 5.46%Dr Edwin Snape (2) 21,687 - 3,116,706 4.48%Peter Smedvig (3) 21,687 - 1,051,071 1.51%Andy Hill - - 42,857 0.06%Ewan Phillips - 12,100 477,814 0.69%George Flouty 25,024 - 189,309 0.27% Total 98,518 100,000 8,675,694 12.47% (1) Includes 589,700 shares held as trustee and executor of Pauline Thomas Charity Will Trust. (2) Includes shares held as a director of New England Partners and associated companies. (3) Includes shares held as director of Peder Smedvig Capital AS. For further information, please contact:- Deltex Medical Group plc 01243 774 837 Nigel Keen, Chairman nigel.keen@deltexmedical.comAndy Hill, Chief Executive andy.hill@deltexmedical.comEwan Phillips, Finance Director ewan.phillips@deltexmedical.com Charles Stanley 0207 739 2000 Philip Davies Financial Dynamics David Yates/Lucy Briggs 0207 831 3113 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
21st Feb 20257:00 amRNSCancellation - Deltex Medical Group Plc
12th Feb 20251:26 pmRNSResult of General Meeting
11th Feb 20256:09 pmRNSHolding in Company
11th Feb 20254:29 pmRNSHolding(s) in Company
10th Feb 20257:00 amRNSHolding in Company
5th Feb 202510:35 amRNSHolding(s) in Company
29th Jan 20253:07 pmRNSHolding(s) in Company
21st Jan 20257:00 amRNSProposed cancellation of trading on AIM
20th Jan 20254:28 pmRNSHolding(s) in Company
20th Jan 20257:00 amRNSHolding(s) in Company
16th Jan 20257:00 amRNSYear-end trading update and proposed cancellation
2nd Dec 20243:20 pmRNSHolding in Company
23rd Sep 20247:00 amRNSInterim results to 30 June 2024
11th Jul 202412:29 pmRNSHolding in Company
10th Jul 202411:46 amRNSHolding in Company
4th Jul 20247:00 amRNSHalf-year Trading Update
12th Jun 20247:00 amRNSNew share plans and grant of share options
4th Jun 20247:00 amRNSAward to NHS Supply Chain Framework Agreement
8th May 202412:50 pmRNSResult of Annual General Meeting
8th May 20247:00 amRNSChairman’s Statement to the Annual General Meeting
8th Apr 20245:03 pmRNSHolding(s) in Company
8th Apr 20247:00 amRNSPosting of Annual Report & Notice of AGM
28th Mar 20247:00 amRNSResults for the year ended 31 December 2023
2nd Feb 20245:11 pmRNSHolding(s) in Company
31st Jan 20245:00 pmRNSTotal Voting Rights
18th Jan 20245:01 pmRNSIssue of Equity
18th Jan 20247:00 amRNSYear-end trading update
4th Dec 20237:00 amRNSCommercial update, board changes & new auditor
18th Sep 20237:00 amRNSInterim results to 30 June 2023
31st Aug 20235:00 pmRNSTotal Voting Rights
2nd Aug 20236:23 pmRNSHolding(s) in Company
2nd Aug 20235:32 pmRNSHolding(s) in Company
2nd Aug 20238:00 amRNSFundraising completion, trading restoration & TVR
2nd Aug 20237:30 amRNSRestoration - Deltex Medical Group PLC
1st Aug 202310:04 amRNSResult of General Meeting
24th Jul 20237:00 amRNSResult of Retail Offer
18th Jul 20234:47 pmRNSExtension of Retail Offer Closing Time
14th Jul 20236:03 pmRNSRetail offer to raise up to £500,000
14th Jul 20236:01 pmRNSPlacing, Subscription and Retail Offer
10th Jul 20237:00 amRNSRelease of new next generation TrueVue System
6th Jul 20237:13 amRNSHalf-year Trading Update & Potential Fundraise
26th Jun 20237:30 amRNSSuspension - Deltex Medical Group PLC
26th Jun 20237:00 amRNSTrading update and suspension of trading on AIM
19th May 20231:35 pmRNSHolding(s) in Company
17th May 20233:24 pmRNSResult of AGM
17th May 20237:00 amRNSChairman’s Statement to the Annual General Meeting
28th Apr 20235:00 pmRNSTotal Voting Rights
25th Apr 20237:00 amRNSNew monitor launch update & new loan facility
11th Apr 20235:43 pmRNSIssue of Equity
30th Mar 20237:00 amRNSResults for the year ended 31 December 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.